Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Engine Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Combining the power of liquid biopsy and AI-driven epigenetics, we deliver accurate cancer detection. Our approach transforms diagnostics…
Altum Sequencing delivers ultra-sensitive ctDNA detection for cancer monitoring and MRD assessment. Precision liquid biopsy solutions for…
SIGNATUR BIO51-200 employees
Expanding PCR testing to a whole new range of conditions. Making precision diagnostics accessible around the planet. Our technology…
Anvil Diagnostics develops MycoScan™, a rapid 3-hour pan-fungal liquid biopsy for invasive fungal infections using proprietary SKIP-Seq™…
Take control of your health with Eugene. Doctor-recommended genetic tests for preconception, pregnancy, and preventive health. Shop now for…
Elypta51-200 employees
Early detection of cancer starts with knowing who is at risk. Elypta provides the missing dynamic biological signal that unlocks risk…

Overview

Identifying recurrence risk before cancer spreads Doctor, did you get it all? Learn about LymphDetect™ Please see our press release on our NVIDIA collaboration! Read more The centrality of the lymphatic system in metastasis has been recognized for over fifty years.

News

Press release PRNewswire 7 months ago
Droplet Biosciences Accelerates Residual Cancer Detection with NVIDIA
/PRNewswire/ -- Droplet Biosciences, a diagnostics company pioneering lymph-based liquid biopsy testing, today announced that it is dramatically reducing...
Read more
Report